Shimadzu Scientific Instruments, Inc. (SSI), a Shimadzu Group company in the United States, has established an R&D centre to enhance its product development capabilities for analytical and measurement equipment. The R&D centre consists of three locations, with one laboratory located at SSI’s headquarters in Maryland, an East Coast (near Boston, Massachusetts) laboratory, and a West Coast (near San Francisco, California) laboratory.

The North American market is a region where investment in advanced technologies and products is strong. Through the R&D centre, Shimadzu will be able to accurately understand customer needs and accelerate product and technology development.

At its headquarters in Maryland, the R&D centre will be used to evaluate prototypes and undertake agile development in cooperation with the Analytical and Measuring Instruments Division of Shimadzu Corporation. The Maryland headquarters will also include laboratories for the installation of prototypes and new products and for conducting joint research with customers. The Japan-headquartered Shimadzu Group plans to use its SSI base to expand its business to pharmaceutical companies, increasing sales in North America from 51 billion yen in fiscal 2022 to more than 70 billion yen in fiscal 2025.